Ads
related to: merck pharmaceuticals products- Before & After Photos
See the Before and After of What
A Treatment Option Can Do For You.
- Side Effects
What You Need To Know
About Benefits and Side Effects
- Psoriasis Symptoms
Learn More Information About
The Symptoms of Plaque Psoriasis.
- Sign Up for Info
Get Updates, Answers, and Resources
For Treatment Support
- Save With Insurance
Get Help & Information to Make
Your Co-Pay More Affordable.
- Patient Stories
Watch Videos of Real Psoriasis
Patients Sharing Their Stories.
- Before & After Photos
opvee.com has been visited by 10K+ users in the past month
Search results
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 2 days agoClinic. Drugs including Regeneron Pharmaceuticals’ Eylea, which had $5.9 billion in sales last year,...
Merck to Acquire EyeBio
Morningstar· 2 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today ...
Merck eyes purchase of ophthalmology company
WFMZ Eastern Pennsylvania and Western New Jersey· 1 day agoTake Merck, for example. Its blockbuster cancer drug, Keytruda, is now the largest selling drug in the world. In the past few weeks, studies have shown...
Merck introduces sterility testing solution for pharma quality control
Pharmaceutical Technology via Yahoo Finance· 2 days agoMerck KGaA, based in Darmstadt, Germany, has introduced the M-Trace Software & Mobile App, designed...
Health Care Roundup: Market Talk
The Wall Street Journal· 8 hours agoThe laboratory-supplies company says it now expects a bigger than expected drop in its end-markets, especially in the pharmaceutical industry, which it...
Merck & Co. sees clear vision to new ophthalmology assets with $3B EyeBio buy
FierceBiotech· 2 days agoMerck & Co. is focusing in on eye diseases with the $3 billion acquisition of ophthalmology-focused Eyebiotech. Merck will take on a pipeline of vision ...
Unveiling Merck (MRK)'s Value: Is It Really Priced Right? A Comp
Guru Focus· 3 days agoMerck & Co Inc (MRK, Financial) recently experienced a daily loss of 2.46%, contributing to a three-month decline of 0.74%. With an Earnings Per Share (EPS) of 0.9, the question ...
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report...
Benzinga· 4 days agoWestern pharmaceutical companies and investors are driving a record number of licensing deals with...
Merck Announces Third-Quarter 2024 Dividend
Morningstar· 2 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.77 per share of ...
Dr. Reddy’s promotes 18-year exec to lead North America business
NJBIZ· 19 hours agoMilan Kalawadia succeeds Marc Kikuchi as chief executive officer, North America. Kalawadia will also...
